Serum tumour markers CA 15-3, TPA, TPS, hCG β and TATI in the monitoring of chemotherapy response in metastatic breast cancer

Author： Sjöström J.   Alfthan H.   Joensuu H.   Stenman U.-H.   Lundin J.   Blomqvist C.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.61, Iss.6, 2001-09, pp. : 431-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 180-187

Karger

Access to resources Recommend Favorite

Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy?

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 39-42

Karger

Access to resources Recommend Favorite

Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone‐metastatic breast cancer

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 5, 2015-04 ,pp. : 760-772

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 175-181

Karger

Access to resources Recommend Favorite

Complete and Sustained Response with a Doublet Chemotherapy Protocol in an 81-Year-Old Patient with Metastatic Breast Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 580-585

Karger

Access to resources Recommend Favorite